NanoRepro AG (NN6):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:NanoRepro AG (NN6) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7874
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NanoRepro AG (NanoRepro) is a manufacturer of fast-diagnostics and nutritional food supplements for home and clinical use. The company offers wide range of rapid diagnostic tests products in the areas of family planning, disease detection (preventive healthcare), food intolerances, allergies and infectious diseases. Its products portfolio includes ovuquick, graviquick, glutencheck, cholesterincheck, fertiquick, vagiquick, menoquick, graviquick fruhtest, fobcheck, heli-c-check, alkoholtest, milkcheck, allergocheck, and eiercheck. The company works in partnership with companies and institutions including University of Marburg, Research Center for Medical Engineering and Biotechnology, Bad Langensalza, Germany. Dedicare AB, Hartmann USA, Inc., Farmaceutica Remedia SA, and others. The Company markets its products through a network of distributors worldwide. NanoRepro is headquartered in Marburg, Germany.

NanoRepro AG (NN6) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NanoRepro AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NanoRepro AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NanoRepro AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NanoRepro AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
NanoRepro AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
NanoRepro AG, Medical Equipment, Deal Details 10
Partnerships 10
NanoRepro Enters into Distribution Agreement with Glenmark South Africa 10
Global Pharma Enters into Contract with NanoRepro 11
Equity Offering 12
Nanorepro Raises USD1 Million in Private Placement of Shares 12
Nanorepro Raises USD0.6 Million in Rights Offering of Shares 13
NanoRepro Raises USD1 Million in Rights Offering of Shares 14
NanoRepro to Raise Funds through Public Offering of Shares 15
NanoRepro Raises USD1.7 Million in Rights Offering of Shares 16
NanoRepro Raises USD1.1 Million in Rights Offering of Shares 17
NanoRepro AG – Key Competitors 18
NanoRepro AG – Key Employees 19
NanoRepro AG – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Financial Announcements 21
Apr 25, 2018: NanoRepro Increases Sales and Achieves Positive Operating Result (EBITDA) 21
Dec 05, 2017: NanoRepro With Higher Sales and Better Results 22
Aug 03, 2017: NanoRepro Increases Growth in the Second Quarter 23
Apr 25, 2017: NanoRepro: Sales Grow in the First Quarter 24
Apr 21, 2017: NanoRepro: Company Expects Revenue to Increase by at Least 30% in 2017 25
Jan 25, 2017: NanoRepro Announces Preliminary Figures for the 2016 Financial Year 26
Other Significant Developments 27
Apr 10, 2018: NanoRepro Reaches Its Annual Targets and Wants to Grow Strongly in 2018 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
NanoRepro AG, Medical Equipment, Key Facts, 2017 2
NanoRepro AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
NanoRepro AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NanoRepro AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
NanoRepro AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NanoRepro AG, Deals By Market, 2012 to YTD 2018 8
NanoRepro AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
NanoRepro Enters into Distribution Agreement with Glenmark South Africa 10
Global Pharma Enters into Contract with NanoRepro 11
Nanorepro Raises USD1 Million in Private Placement of Shares 12
Nanorepro Raises USD0.6 Million in Rights Offering of Shares 13
NanoRepro Raises USD1 Million in Rights Offering of Shares 14
NanoRepro to Raise Funds through Public Offering of Shares 15
NanoRepro Raises USD1.7 Million in Rights Offering of Shares 16
NanoRepro Raises USD1.1 Million in Rights Offering of Shares 17
NanoRepro AG, Key Competitors 18
NanoRepro AG, Key Employees 19

List of Figures
NanoRepro AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
NanoRepro AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
NanoRepro AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
NanoRepro AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
NanoRepro AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
NanoRepro AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
NanoRepro AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
NanoRepro AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[NanoRepro AG (NN6):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dentsply Sirona, Inc.:企業の戦略・SWOT・財務分析
    Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • SYNNEX Corp (SNX):企業の財務・戦略的SWOT分析
    SYNNEX Corp (SNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • AB Volvo:企業の戦略・SWOT・財務分析
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Pharmaxis Ltd (PXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Pharmaxis Ltd (Pharmaxis) is a pharmaceutical research company that develops and commercialize healthcare products. The company provides products such as aridol which identify twitchy and assist in diagnosing and managing asthma, and bronchitol which restores normal lung hydration, improves …
  • AmSurg Corp (EVHC):製薬・医療:M&Aディール及び事業提携情報
    Summary AmSurg Corp (AmSurg) is a healthcare service provider that develops, acquires and operates surgery centers. The company is a surgery center management and development company that manages hospitals and health systems. It provides strategic and operational management of surgery centers that i …
  • Southern Company Gas:電力:M&Aディール及び事業提携情報
    Summary Southern Company Gas (SCG), formerly AGL Resources Inc., is an energy services holding company It operates through natural gas distribution, retail operations, wholesale services and midstream. The company serves utility customers through its regulated distribution subsidiaries in the states …
  • UniCredit S.p.A:企業のM&A・事業提携・投資動向
    UniCredit S.p.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's UniCredit S.p.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Precision System Science Co Ltd (7707):医療機器:M&Aディール及び事業提携情報
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company provide products such as automated nucleic acid isolation system, large sample volume nucleic acid extract …
  • Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析
    Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Desktop Genetics Ltd-医療機器分野:企業M&A・提携分析
    Summary Desktop Genetics Ltd (DeskGen) is a provider of genome editing solutions. The company offers software solutions for the design, synthesis and assembly of DNA. It offers deskgen, which is a software system that helps scientists to organize, optimize, and automate their research. DeskGen’s CRI …
  • Chong Kun Dang Pharmaceutical Corp (185750):企業の財務・戦略的SWOT分析
    Chong Kun Dang Pharmaceutical Corp (185750) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Caldic B.V.:企業の戦略・SWOT・財務情報
    Caldic B.V. - Strategy, SWOT and Corporate Finance Report Summary Caldic B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Dana Gas (DANA):企業の財務・戦略的SWOT分析
    Summary Dana Gas is an oil and gas company that produces natural gas. The company carries out the exploration and production of gas, oil, and natural gas liquids. It offers processing, transportation, distribution, promotion and sales of petroleum and natural gas products. Dana Gas operates Sharjah …
  • Evergreen Fibreboard Berhad:企業の戦略・SWOT・財務情報
    Evergreen Fibreboard Berhad - Strategy, SWOT and Corporate Finance Report Summary Evergreen Fibreboard Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Beazer Homes USA Inc:企業の戦略・SWOT・財務情報
    Beazer Homes USA Inc - Strategy, SWOT and Corporate Finance Report Summary Beazer Homes USA Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Standex International Corp:企業の戦略・SWOT・財務分析
    Standex International Corp - Strategy, SWOT and Corporate Finance Report Summary Standex International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ameritas Mutual Holding Company:企業の戦略的SWOT分析
    Ameritas Mutual Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Profectus BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Profectus BioSciences Inc (Profectus) is a clinical-stage vaccine development company that designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company's products include genevax therapeutic vaccines, vesiculova …
  • TTCL Public Company Limited (TTCL):電力:M&Aディール及び事業提携情報
    Summary TTCL Public Company Limited (TTCL), a subsidiary of Italian-Thai Development Public Company Limited, is a provider of engineering and construction services. The company offers integrated engineering, procurement and construction (EPC) services, feasibility study and project management servic …
  • GFI Informatique:企業の戦略・SWOT・財務情報
    GFI Informatique - Strategy, SWOT and Corporate Finance Report Summary GFI Informatique - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆